Comparative assessment of phospholipid-binding antibodies indicates limited overlapping

Journal of Clinical Laboratory Analysis

Volumn 10, Issue 1, 1996, Pages 6-12

  De Maistre, E ^a,b   Gobert, B ^b   Bene M C ^b   Briquel, M E ^a   Lecompte, T ^a   Faure, G C ^a,b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

anticardiolipin antibodies; coagulation; ELISA; lupus anticoagulant; phosphat idic acid; phosphatidylcholine; phosphatidylethanolamine; phosphatidylinositol; phosphatidylserine

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; BLOOD CLOTTING TEST; BLOOD SAMPLING; BRAIN ISCHEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; BINDING SITES, ANTIBODY; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PHOSPHATIDIC ACIDS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLINOSITOLS; PHOSPHATIDYLSERINES;

EID: 0030044383     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1996)10:1<6::AID-JCLA2>3.0.CO;2-C     Document Type: Article

References (20)

1. Bowie EJ, Thompson JH, Pascuzzi CA, Owen JR: Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 162:417-430, 1963.
2. Nilsson IM, Astedt B, Hedner U, Berezin D: Intrauterine death and circulating anticoagulant. Acta Med Scand 197:153-159, 1975.
3. Harris EN, Gharavi AE, Patel SP, Hughes GRV: Evaluation of the anticardiolipin test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 68:215-222, 1987.
4. Triplett DA, Brandt JT: Lupus anticoagulants: Misnomer, paradox, riddle, epiphenomenon. Hematol Pathol 2:121-143, 1988.
5. Asherson RA: Antiphospholipid antibodies: Clinical complications reported in the medical literature. In Phospholipid Binding Antibodies. EN Harris, T Exner, GRV Hughes, RA Asherson, eds. CRC Press, Boca Raton, FL, 1991, p 387-402.
6. Harris EN: Syndrome of the Black Swan. Br J Rheumatol 26:324-326, 1987.
7. Thiagarajan P, Shapiro SS, Demarco L: Monoclonal immunoglobulin lambda-M coagulation inhibitor with phospholipid specificity. J Clin Invest 66:397-405, 1980.
8. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA: Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 66:629-632, 1991.
9. Galli M, Comfurius P, Barbui T, Zwaal RFA, Bevers EM: Anticoagulant activity of beta-2 glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 68:297-300, 1992.
10. Rosner E, Pauzer R, Lusky A, Modan M: Detection and quantitative evaluating of lupus circulating anticoagulant activity. Thromb Haemost 57:144-147, 1977.
11. Barbaud A, Gobert B, Reichen S, Schmutz JL, Béné MC, Weber M, Faure GC: Anticardiolipin antibodies and ulcerations of the leg. J Am Acad Dermatol 31:670-671, 1994.
12. McNeil HP, Simpson RJ, Chesterman CN, Krillis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta-2 glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120-4124, 1990.
13. Toschi V, Motta A, Castelli C, Gibelli S, Cimminiello C, Molaro GL, Gibelli A: Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus. Haemostasis 23:275-283, 1993.
14. Gharavi AE, Harris EN, Asherson RA, Hughes GRV: Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 46:1-6, 1987.
15. Vlachoyiannopoulos PG, Beigbeder G, Dueymes M, Youinou P, Hunt JE, Krilis SA, Moutsopoulos HM: Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: Their relation with anticardiolipin antibodies and beta-2 glycoprotein I plasma levels. Autoimmunity 16:245-249, 1993.
16. Zwaal RFA, Hemker H: Blood cell membranes and haemostasis. Haemostasis 11:12-39, 1982.
17. Rauch J, Tannenbaum M, Janoff AS: Distinguishing plasma lupus anti-coagulant from antifactor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 62:892-896, 1989.
18. Pengo V, Thiagarajan P, Shapiro S, Heine M: Immunological specificity and mechanism of action of IgG lupus anticoagulant. Blood 70:69-76, 1987.
19. Branch DW, Rote NJ, Dostal S Jr: Association of lupus anticoagulant with antibodies against phosphatidylserine. Clin Immunol Immunopathol 42:63-75, 1987.
20. Blank M, Tincani A, Shoenfeld Y: Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 21:100-104, 1994.